NSPR vs. HSAQ, DRIO, ICCM, AMIX, APYX, SEPA, MGRM, LUCD, NVNO, and PDEX
Should you be buying InspireMD stock or one of its competitors? The main competitors of InspireMD include Health Sciences Acquisitions Co. 2 (HSAQ), DarioHealth (DRIO), IceCure Medical (ICCM), Autonomix Medical (AMIX), Apyx Medical (APYX), SEP Acquisition (SEPA), Monogram Orthopaedics (MGRM), Lucid Diagnostics (LUCD), enVVeno Medical (NVNO), and Pro-Dex (PDEX). These companies are all part of the "surgical & medical instruments" industry.
InspireMD (NYSE:NSPR) and Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, earnings, valuation, media sentiment, analyst recommendations, community ranking, institutional ownership and profitability.
Health Sciences Acquisitions Co. 2 has a net margin of 0.00% compared to InspireMD's net margin of -350.35%. Health Sciences Acquisitions Co. 2's return on equity of 0.00% beat InspireMD's return on equity.
InspireMD presently has a consensus target price of $4.85, suggesting a potential upside of 115.56%. Given InspireMD's higher possible upside, research analysts plainly believe InspireMD is more favorable than Health Sciences Acquisitions Co. 2.
Health Sciences Acquisitions Co. 2 has lower revenue, but higher earnings than InspireMD.
In the previous week, InspireMD had 5 more articles in the media than Health Sciences Acquisitions Co. 2. MarketBeat recorded 7 mentions for InspireMD and 2 mentions for Health Sciences Acquisitions Co. 2. Health Sciences Acquisitions Co. 2's average media sentiment score of 0.38 beat InspireMD's score of -0.76 indicating that Health Sciences Acquisitions Co. 2 is being referred to more favorably in the news media.
44.8% of InspireMD shares are owned by institutional investors. Comparatively, 89.7% of Health Sciences Acquisitions Co. 2 shares are owned by institutional investors. 29.7% of InspireMD shares are owned by insiders. Comparatively, 21.9% of Health Sciences Acquisitions Co. 2 shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
InspireMD received 2 more outperform votes than Health Sciences Acquisitions Co. 2 when rated by MarketBeat users.
InspireMD has a beta of 0.92, meaning that its stock price is 8% less volatile than the S&P 500. Comparatively, Health Sciences Acquisitions Co. 2 has a beta of 0.09, meaning that its stock price is 91% less volatile than the S&P 500.
Summary
InspireMD beats Health Sciences Acquisitions Co. 2 on 7 of the 13 factors compared between the two stocks.
Get InspireMD News Delivered to You Automatically
Sign up to receive the latest news and ratings for NSPR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NSPR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
InspireMD Competitors List
Related Companies and Tools
